List view / Grid view
15 February 2016 | By Victoria White
Eisai and Charles River have signed a collaboration agreement which will see Charles River scientists work at Eisai’s research and development facilities in Hatfield...
15 February 2016 | By Victoria White
In addition to establishing the potential for CMV-based vaccines against Ebola virus, these results are exciting from the potential insight they give into the mechanism of protection...
12 February 2016 | By Victoria White
The latest report from the Review on Antimicrobial Resistance says that vaccines and other alternatives can play a vital role in tackling the rise of drug-resistant infections...
12 February 2016 | By Victoria White
Scientists tested nimbolide, natural extract derived from India's neem tree, against pancreatic cancer in cell lines and mice...
11 February 2016 | By Victoria White
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms...
11 February 2016 | By Victoria White
The European Society of Cardiology awarded the grants to research projects that will address areas of unmet medical need in thromboembolic disease...
10 February 2016 | By Victoria White
Regeneron has joined the Human Vaccines Project, a public-private partnership to help discover and develop new vaccines and immunotherapies...
10 February 2016 | By Victoria White
Emory University scientists have found that specific types of bacteria step forward to promote healing in injured mouse intestines...
10 February 2016 | By Victoria White
The team from University of Alberta is the first ever to find a way to bond neurons and in doing so, has given researchers a powerful new tool...
9 February 2016 | By Victoria White
The programme aims to bring together breast cancer researchers and pharmaceutical companies to pool resources and stop women dying from breast cancer by 2050...
9 February 2016 | By Victoria White
ESCMID experts are developing tools to monitor the spread of Zika and are conducting research to gather more solid data to better assess the risks...
9 February 2016 | By Victoria White
The research will be led at Baylor by Professor Huda Zoghbi who is world renowned in the field of neurodegenerative disease research...
8 February 2016 | By SMi Group
SMi will open its doors to host RNA Therapeutics 2016 in just 1 week on 15th and 16th February in Central London...
8 February 2016 | By Victoria White
Biogen’s new membership follows the launch of the new CTTV Target Validation Platform, which helps researchers identify therapeutic targets for new medicines...
8 February 2016 | By Victoria White
Peptidyl arginine deiminase 4 (PAD4) is a protein that plays a role in the development of inflammatory diseases like arthritis...
